Future Specialty Care Portfolio Strategy Lead – US Specialty Care (12 Month Secondment)  jobs in United States
cer-icon
Apply on Employer Site
company-logo

Pfizer · 2 days ago

Future Specialty Care Portfolio Strategy Lead – US Specialty Care (12 Month Secondment) 

Pfizer is a leading pharmaceutical company, and they are seeking a Future Specialty Care Portfolio Strategy Lead. This role involves developing a long-term portfolio strategy for Specialty Care in the US, collaborating across various departments to ensure market readiness and strategic alignment for future product launches.

BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
badNo H1Bnote

Responsibilities

Develop and articulate the long-term Specialty Care portfolio vision for the US, ensuring alignment between today’s portfolio and future pipeline assets
Identify strategic gaps, unmet needs, and opportunities to strengthen the portfolio’s competitive positioning
US lead for portfolio scenario planning, future readiness assessments, and strategic prioritization for investment and resource alignment
Deliver a US market implementation roadmap for 2026-2028 with interdependencies and clear execution plans for each stakeholder, including actions by cross-functional owners, milestones, and deliverable deadlines to address readiness gaps
Outline and begin pre-launch US market engagement activities to shape and validate the market opportunity with key stakeholders, such thought leader engagement, conference attendance, and conducting product theaters or ad boards
Collaborate closely with Therapeutic Area Leads and Medical to translate disease area trends, evolving science, and unmet needs into future strategic priorities
Work with CSI, Medical, and Global Marketing to shape positioning, value propositions, and market readiness for early and late-stage pipeline assets
Engage with R&D and Medical to align scientific direction with strategic priorities, ensuring future assets address key growth opportunities
Partner with CSI/GCA to integrate market trends, environmental dynamics, competitive intelligence, and customer insight into future portfolio planning
Partner with BD&L to inform external opportunity scanning, ensuring alignment with portfolio strategy and identified unmet needs
Define strategic criteria and therapeutic priorities to guide BD&L in asset identification and evaluation
Support scientific and commercial assessments of external opportunities, including valuations and strategic fit analysis
Contribute to internal alignment and recommendation processes to secure support for BD&L-informed strategic directions
Lead the development of a comprehensive US Respiratory strategy, including preparation plans for trispecific launch and future R&D portfolio launches
Assess emerging science, competitive dynamics, and evolving market landscapes in respiratory
Define long-term Respiratory positioning, launch pathways, and cross-functional readiness milestones and owners
Synthesize complex insights into clear, strategic recommendations for senior leadership, including the President of US Specialty Care
Lead executive-level discussions on portfolio prioritization, sequencing, investment, and external commercial opportunity alignment
Drive cross-functional alignment to ensure cohesive execution of the Specialty Care future strategy

Qualification

Portfolio ManagementStrategic PlanningBusiness DevelopmentMarket AnalysisCross-Functional LeadershipStrategic StorytellingInfluencing SkillsCommunication SkillsStrategic Thinking

Required

12+ years in strategy, new product planning, portfolio management, BD&L collaboration, or related roles in Specialty Care TAs or respiratory
Strong experience influencing strategic decisions across cross-functional teams, including R&D, BD&L, Marketing, Medical, and Finance
Proven ability to lead strategic planning, portfolio shaping, and valuation of business opportunities
Exceptional communication, executive engagement, and strategic storytelling skills
Strong strategic thinking, ability to navigate ambiguity, and comfort operating at the enterprise level

Benefits

Relocation assistance may be available based on business needs and/or eligibility.

Company

Pfizer is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines.

Funding

Current Stage
Public Company
Total Funding
$38B
Key Investors
Starboard Value
2025-11-21Post Ipo Debt· $6B
2024-10-07Post Ipo Equity· $1B
2023-05-16Post Ipo Debt· $31B

Leadership Team

leader-logo
Albert Bourla
Chief Executive Officer
linkedin
leader-logo
Ian Read
Chief Executive Officer
linkedin
Company data provided by crunchbase